Literature DB >> 29224781

Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10.

Tom C M Seegar1, Lauren B Killingsworth1, Nayanendu Saha2, Peter A Meyer3, Dhabaleswar Patra4, Brandon Zimmerman1, Peter W Janes5, Eric Rubinstein6, Dimitar B Nikolov2, Georgios Skiniotis7, Andrew C Kruse1, Stephen C Blacklow8.   

Abstract

Cleavage of membrane-anchored proteins by ADAM (a disintegrin and metalloproteinase) endopeptidases plays a key role in a wide variety of biological signal transduction and protein turnover processes. Among ADAM family members, ADAM10 stands out as particularly important because it is both responsible for regulated proteolysis of Notch receptors and catalyzes the non-amyloidogenic α-secretase cleavage of the Alzheimer's precursor protein (APP). We present here the X-ray crystal structure of the ADAM10 ectodomain, which, together with biochemical and cellular studies, reveals how access to the enzyme active site is regulated. The enzyme adopts an unanticipated architecture in which the C-terminal cysteine-rich domain partially occludes the enzyme active site, preventing unfettered substrate access. Binding of a modulatory antibody to the cysteine-rich domain liberates the catalytic domain from autoinhibition, enhancing enzymatic activity toward a peptide substrate. Together, these studies reveal a mechanism for regulation of ADAM activity and offer a roadmap for its modulation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADAM10; Notch signaling; X-ray crystallography; amyloid precursor protein

Mesh:

Substances:

Year:  2017        PMID: 29224781      PMCID: PMC5773094          DOI: 10.1016/j.cell.2017.11.014

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  58 in total

1.  EMAN: semiautomated software for high-resolution single-particle reconstructions.

Authors:  S J Ludtke; P R Baldwin; W Chiu
Journal:  J Struct Biol       Date:  1999-12-01       Impact factor: 2.867

2.  The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex.

Authors:  Ellen Jorissen; Johannes Prox; Christian Bernreuther; Silvio Weber; Ralf Schwanbeck; Lutgarde Serneels; An Snellinx; Katleen Craessaerts; Amantha Thathiah; Ina Tesseur; Udo Bartsch; Gisela Weskamp; Carl P Blobel; Markus Glatzel; Bart De Strooper; Paul Saftig
Journal:  J Neurosci       Date:  2010-04-07       Impact factor: 6.167

3.  Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.

Authors:  Peter W Janes; Nayanendu Saha; William A Barton; Momchil V Kolev; Sabine H Wimmer-Kleikamp; Eva Nievergall; Carl P Blobel; Juha-Pekka Himanen; Martin Lackmann; Dimitar B Nikolov
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

Review 4.  The ADAMs: signalling scissors in the tumour microenvironment.

Authors:  Gillian Murphy
Journal:  Nat Rev Cancer       Date:  2008-11-13       Impact factor: 60.716

Review 5.  The metalloproteinase ADAM10: A useful therapeutic target?

Authors:  Sebastian Wetzel; Lisa Seipold; Paul Saftig
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-06-15       Impact factor: 4.739

Review 6.  Ectodomain shedding and ADAMs in development.

Authors:  Silvio Weber; Paul Saftig
Journal:  Development       Date:  2012-10       Impact factor: 6.868

7.  Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1.

Authors:  J C Aster; L Xu; F G Karnell; V Patriub; J C Pui; W S Pear
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

8.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts.

Authors:  Dieter Hartmann; Bart de Strooper; Lutgarde Serneels; Katleen Craessaerts; An Herreman; Wim Annaert; Lieve Umans; Torben Lübke; Anna Lena Illert; Kurt von Figura; Paul Saftig
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

9.  Cross-domain inhibition of TACE ectodomain.

Authors:  Christopher J Tape; Sofie H Willems; Sarah L Dombernowsky; Peter L Stanley; Marton Fogarasi; Willem Ouwehand; John McCafferty; Gillian Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

10.  ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer.

Authors:  Katharina Feldinger; Daniele Generali; Gabriela Kramer-Marek; Merel Gijsen; T B Ng; Jack Ho Wong; Carla Strina; Mariarosa Cappelletti; Daniele Andreis; Ji-Liang Li; Esther Bridges; Helen Turley; Russell Leek; Ioannis Roxanis; Jacek Capala; Gillian Murphy; Adrian L Harris; Anthony Kong
Journal:  Oncotarget       Date:  2014-08-30
View more
  45 in total

Review 1.  Key metalloproteinase-mediated pathways in the kidney.

Authors:  Tammo Ostendorf; Andreas Ludwig; Justyna Wozniak; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2021-04-20       Impact factor: 28.314

2.  Domain integration of ADAM family proteins: Emerging themes from structural studies.

Authors:  Tom Cm Seegar; Stephen C Blacklow
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-23

3.  Degradome of soluble ADAM10 and ADAM17 metalloproteases.

Authors:  Franka Scharfenberg; Andreas Helbig; Martin Sammel; Julia Benzel; Uwe Schlomann; Florian Peters; Rielana Wichert; Maximilian Bettendorff; Dirk Schmidt-Arras; Stefan Rose-John; Catherine Moali; Stefan F Lichtenthaler; Claus U Pietrzik; Jörg W Bartsch; Andreas Tholey; Christoph Becker-Pauly
Journal:  Cell Mol Life Sci       Date:  2019-06-17       Impact factor: 9.261

Review 4.  On the cutting edge: protease-based methods for sensing and controlling cell biology.

Authors:  H Kay Chung; Michael Z Lin
Journal:  Nat Methods       Date:  2020-07-13       Impact factor: 28.547

5.  In Search of Selectivity in Inhibition of ADAM10.

Authors:  Kiran V Mahasenan; Derong Ding; Ming Gao; Trung T Nguyen; Mark A Suckow; Valerie A Schroeder; William R Wolter; Mayland Chang; Shahriar Mobashery
Journal:  ACS Med Chem Lett       Date:  2018-06-11       Impact factor: 4.345

Review 6.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

7.  Deep profiling of protease substrate specificity enabled by dual random and scanned human proteome substrate phage libraries.

Authors:  Jie Zhou; Shantao Li; Kevin K Leung; Brian O'Donovan; James Y Zou; Joseph L DeRisi; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-24       Impact factor: 11.205

8.  Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains.

Authors:  Beiyu Tang; Xue Li; Thorsten Maretzky; Jose Manuel Perez-Aguilar; David McIlwain; Yifang Xie; Yufang Zheng; Tak W Mak; Harel Weinstein; Carl P Blobel
Journal:  FASEB J       Date:  2020-02-26       Impact factor: 5.191

Review 9.  Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding.

Authors:  Franka Scharfenberg; Fred Armbrust; Liana Marengo; Claus Pietrzik; Christoph Becker-Pauly
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

10.  The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradation.

Authors:  Tobias Brummer; Martina Pigoni; Armando Rossello; Huanhuan Wang; Peter J Noy; Michael G Tomlinson; Carl P Blobel; Stefan F Lichtenthaler
Journal:  FASEB J       Date:  2018-02-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.